Paper26324801
Pulmonary hypertension in patients with chronic myeloproliferative disorders.
Adir Y and 2 others. Eur Respir Rev, 2015. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Pulmonary hypertension in patients with chronic myeloproliferative disorders. Papers, record 26324801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26324801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arterial Pressure | Major topic |
| Hypertension, Pulmonary | Major topic |
| Myeloproliferative Disorders | Major topic |
| Pulmonary Artery | Major topic |
| Animals | |
| Antihypertensive Agents | |
| Chronic Disease | |
| Endarterectomy | |
| Humans | |
| Protein Kinase Inhibitors | |
| Risk Assessment | |
| Risk Factors | |
| Thromboembolism | |
| Treatment Outcome |
Source PubMed
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17851555 | Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. | Leukemia | 2008 | https://conductscience.org/library/papers/17851555 | PubMed |
| 2 | 16325696 | Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. | Lancet | 2005 | https://conductscience.org/library/papers/16325696 | PubMed |
| 3 | 3865532 | The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. | Am J Hematol | 1985 | https://conductscience.org/library/papers/3865532 | PubMed |
| 4 | 19389575 | ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. | J Am Coll Cardiol | 2009 | https://conductscience.org/library/papers/19389575 | PubMed |
| 5 | 20530034 | Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. | Eur Respir J | 2010 | https://conductscience.org/library/papers/20530034 | PubMed |
| 6 | 8988890 | Primary pulmonary hypertension. | N Engl J Med | 1997 | https://conductscience.org/library/papers/8988890 | PubMed |
| 7 | 17128687 | Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. | J Natl Med Assoc | 2006 | https://conductscience.org/library/papers/17128687 | PubMed |
| 8 | 19118230 | Pulmonary veno-occlusive disease. | Eur Respir J | 2009 | https://conductscience.org/library/papers/19118230 | PubMed |
| 9 | 9747171 | Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging. | World J Surg | 1998 | https://conductscience.org/library/papers/9747171 | PubMed |
| 10 | 16926298 | Circulating CD34+ cells, pulmonary hypertension, and myelofibrosis. | Blood | 2006 | https://conductscience.org/library/papers/16926298 | PubMed |
| 11 | 9387199 | Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. | Semin Thromb Hemost | 1997 | https://conductscience.org/library/papers/9387199 | PubMed |
| 12 | 23614764 | Pulmonary hypertension in patients with chronic myeloproliferative neoplasms. | Leuk Lymphoma | 2014 | https://conductscience.org/library/papers/23614764 | PubMed |
| 13 | 1442851 | Cardiac involvement in patients with myeloproliferative disorders. | Am J Med | 1992 | https://conductscience.org/library/papers/1442851 | PubMed |
| 14 | 17110452 | Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. | Blood | 2007 | https://conductscience.org/library/papers/17110452 | PubMed |
| 15 | 18160817 | Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. | Respiration | 2008 | https://conductscience.org/library/papers/18160817 | PubMed |
| 16 | 11921022 | Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement. | Am J Hematol | 2002 | https://conductscience.org/library/papers/11921022 | PubMed |
| 17 | 15781101 | Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | Lancet | 2005 | https://conductscience.org/library/papers/15781101 | PubMed |
| 18 | 8369443 | Aggregation and disaggregation kinetics of human blood platelets: Part III. The disaggregation under shear stress of platelet aggregates. | Biophys J | 1993 | https://conductscience.org/library/papers/8369443 | PubMed |
| 19 | 21719499 | Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. | Eur Respir J | 2011 | https://conductscience.org/library/papers/21719499 | PubMed |
| 20 | 15585978 | Severe pulmonary hypertension in chronic idiopathic myelofibrosis. | Onkologie | 2004 | https://conductscience.org/library/papers/15585978 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42621166 | Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study. | Ther Adv Hematol | 2026 | https://conductscience.org/library/papers/42621166 | PubMed |
| 41818347 | Targeting the Hippo pathway in pulmonary arterial hypertension: emerging pharmacological strategies. | J Hypertens | 2026 | https://conductscience.org/library/papers/41818347 | PubMed |
| 40257482 | Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms. | Ann Hematol | 2025 | https://conductscience.org/library/papers/40257482 | PubMed |
| 39693509 | High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera. | Blood Adv | 2025 | https://conductscience.org/library/papers/39693509 | PubMed |
| 36700179 | Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera. | CJC Open | 2023 | https://conductscience.org/library/papers/36700179 | PubMed |
| 35420683 | Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. | Blood Adv | 2023 | https://conductscience.org/library/papers/35420683 | PubMed |
| 34900042 | Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study. | Arch Med Sci | 2021 | https://conductscience.org/library/papers/34900042 | PubMed |
| 34545058 | Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report. | Am J Case Rep | 2021 | https://conductscience.org/library/papers/34545058 | PubMed |
| 34158919 | Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension. | Pulm Circ | 2021 | https://conductscience.org/library/papers/34158919 | PubMed |
| 33785036 | Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice. | J Hematol Oncol | 2021 | https://conductscience.org/library/papers/33785036 | PubMed |
| 33150157 | The role of genomics and genetics in pulmonary arterial hypertension. | Glob Cardiol Sci Pract | 2020 | https://conductscience.org/library/papers/33150157 | PubMed |
| 33024690 | Successful treatment for a patient with chronic thromboembolic pulmonary hypertension comorbid with essential thrombocythemia with the JAK2 V617F mutation by balloon pulmonary angioplasty. | Respir Med Case Rep | 2020 | https://conductscience.org/library/papers/33024690 | PubMed |
| 32700192 | Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients. | Int J Hematol | 2020 | https://conductscience.org/library/papers/32700192 | PubMed |
| 32429621 | Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients. | Blood Res | 2020 | https://conductscience.org/library/papers/32429621 | PubMed |
| 32397294 | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32397294 | PubMed |
| 31918690 | Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report. | BMC Pulm Med | 2020 | https://conductscience.org/library/papers/31918690 | PubMed |
| 31695170 | Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis. | Bone Marrow Transplant | 2020 | https://conductscience.org/library/papers/31695170 | PubMed |
| 30896614 | Pulmonary hypertension with massive megalosplenia: A case report. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/30896614 | PubMed |
| 30149506 | Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30149506 | PubMed |
| 30081463 | Myeloid-Derived Suppressor Cells and Pulmonary Hypertension. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30081463 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26324801
GET https://conductscience.org/api/papers/v1/26324801/references?page=2